2327 — Meilleure Health International Industry Share Price
Last trade - 00:00- HK$1.02bn
- HK$1.30bn
- HK$50.68m
- 54
- 47
- 32
- 39
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.85 | ||
| Price to Tang. Book | 0.85 | ||
| Price to Free Cashflow | 5.5 | ||
| Price to Sales | 20.19 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.89% | ||
| Return on Equity | 2.65% | ||
| Operating Margin | 115.86% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 265.13 | 253.03 | 119.89 | 129.3 | 50.68 | n/a | n/a | -26.41% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +3290.32 | +10.85 | -77.34 | +313.26 | +4.58 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.
Directors
- Wentao Zeng CCH (54)
- Xuzhou Zhou CCH (59)
- Wen Chuan Zhou CEO (31)
- Shu Pai Li CFO (44)
- Zhenhua Mao NED (57)
- Chi Wai Chau NID (51)
- Guanjiang Gao NID (65)
- Peng Wu NID
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 19th, 2002
- Public Since
- October 14th, 2003
- No. of Employees
- 46
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 4,092,562,636
- Address
- Unit 2906, Tower 1, Lippo Centre
- Web
- http://www.meilleure.com.cn
- Phone
- +852 null25631500
- Auditors
- ZHONGHUI ANDA CPA Limited
Latest News for 2327
Upcoming Events for 2327
Similar to 2327
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories (Tianjin) Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 21:58 UTC, shares in Meilleure Health International Industry are trading at HK$0.25. This share price information is delayed by 15 minutes.
Shares in Meilleure Health International Industry last closed at HK$0.25 and the price had moved by +57.23% over the past 365 days. In terms of relative price strength the Meilleure Health International Industry share price has outperformed the FTSE Developed Asia Pacific Index by +41.57% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Meilleure Health International Industry dividend yield is 1.6% based on the trailing twelve month period.
Last year, Meilleure Health International Industry paid a total dividend of HK$0.00, and it currently has a trailing dividend yield of 1.6%.Looking ahead, the next dividend pay date is 2025-08-20.
We do not have data on when Meilleure Health International Industry is to next pay dividends. The historic dividend yield on Meilleure Health International Industry shares is currently 1.6%.
To buy shares in Meilleure Health International Industry you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.25, shares in Meilleure Health International Industry had a market capitalisation of HK$1.02bn.
Here are the trading details for Meilleure Health International Industry:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2327
Based on an overall assessment of its quality, value and momentum Meilleure Health International Industry is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Meilleure Health International Industry. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -30.34%.
As of the last closing price of HK$0.25, shares in Meilleure Health International Industry were trading -9.41% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Meilleure Health International Industry PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Meilleure Health International Industry's management team is headed by:
- Wentao Zeng - CCH
- Xuzhou Zhou - CCH
- Wen Chuan Zhou - CEO
- Shu Pai Li - CFO
- Zhenhua Mao - NED
- Chi Wai Chau - NID
- Guanjiang Gao - NID
- Peng Wu - NID